Relief Therapeutics, NeuroRx get FDA nod to start coronavirus trial
March 29, 2020 at 08:37 AM EDT
The U.S. Food & Drug Administration has authorised the start of a mid-stage trial by U.S.-Israeli NeuroRx and Relief Therapeutics for the use of Aviptadil to treat Acute Respiratory Distress in coronavirus patients.
